Form 4: Molina Healthcare Director Receives Equity Award

Sentiment:

Statement of Changes in Beneficial Ownership


Molina Healthcare, Inc. reports a director, Ronna Romney, received an equity award of 405 shares valued at $135.82 per share on April 1, 2026, as part of her annual compensation.

Summary

  • Ronna Romney, a Director at Molina Healthcare, Inc., was granted 405 shares of common stock on April 1, 2026.
  • This grant is part of her annual equity award for services as a Director, valued at $135.82 per share.
  • The total annual equity award for directors is set at $220,000, with quarterly grants of $55,000.
  • The shares were issued under the Issuer's 2025 Equity Incentive Plan.
  • The securities are held indirectly through the Ronna Romney Revocable Trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine director equity grant and does not contain significant new financial information or strategic shifts.

Positives

  • Director Ronna Romney received an equity award, indicating continued investment in and compensation for key leadership.
  • The award is part of a structured annual equity plan, suggesting a consistent approach to director compensation.
  • The grant is based on the closing stock price on the award date, aligning director compensation with market value.

Risks

  • The value of the equity award is subject to market fluctuations, as the grant is tied to the closing stock price.
  • Potential for conflicts of interest if the trust holding the shares has other investment objectives.

Future Outlook

The filing does not contain specific forward-looking statements or guidance beyond the established director compensation plan.

Management Comments

  • The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day.
  • Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

Industry Context

StockSavvy.ai notes that equity awards to directors are a standard practice in the healthcare industry, aligning director incentives with shareholder value and company performance. The structure of this award, based on stock price, is common among publicly traded companies.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Power of AttorneyRonna Romney has granted a Limited Power of Attorney to Jeff D. Barlow and Codruta Catanescu to execute Section 16(a) filings on her behalf.02/16/2011Facilitates timely and accurate filing of ownership changes, ensuring compliance with SEC regulations.

Stakeholder Impact

  • Shareholders: The equity award aligns director interests with shareholder value, though the direct impact on share price from this single grant is minimal.
  • Employees: The filing is primarily relevant to management and board compensation structures.
  • Management: The filing details compensation for a director, reinforcing standard executive and director compensation practices.

Next Steps

  • Continued quarterly equity grants to directors under the 2025 Equity Incentive Plan.
  • Ongoing compliance with Section 16(a) reporting requirements for beneficial ownership changes.

Key Dates

DateDescription
02/16/2011Date of Power of Attorney for Section 16(a) filings.
04/01/2026Transaction Date for the grant of common stock.
04/02/2026Date of signature for the Form 4 filing.

Keywords

Molina Healthcare, MOH, Form 4, Director Compensation, Equity Award, Stock Grant, Ronna Romney, Beneficial Ownership, SEC Filing, Insider Trading

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.